Executive Brief: Competitive Landscape and Strategic Developments in the Middle EAST Microalbumin Test Market
The Middle EAST Microalbumin Test Market was valued at USD 0.45 billion in 2024 and is projected to reach USD 1.12 billion by 2034, registering a CAGR of 9.2%. This growth trajectory is underpinned by an increasing prevalence of chronic diseases, particularly diabetes and hypertension, which necessitate regular monitoring of microalbumin levels as a key indicator of kidney function. The rising...
0 Комментарии 0 Поделились 56 Просмотры 0 предпросмотр